ARCHIVES

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Proposal To Regulate Tobacco Wins Support Of NCI, Oncology Societies

September 8, 1995

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

FDA Approves Implant For Breast Reconstruction

July 26, 2013

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991

July issue of Business & Regulatory report (8 additional pages) included.

July 30, 2004